Meta-Analysis of EGFR Tyrosine Kinase Inhibitors Compared with Chemotherapy as Second-Line Treatment in Pretreated Advanced Non-Small Cell Lung Cancer

BACKGROUND: Since efficacy and safety of epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) versus chemotherapy in the treatment of patients with pretreated advanced non-small cell lung cancer (NSCLC) remain controversial, we performed a meta-analysis to compare them. METHODS: A...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Ning, Yang, Lu, Ou, Wei, Zhang, Liang, Zhang, Song-liang, Wang, Si-yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4100920/
https://www.ncbi.nlm.nih.gov/pubmed/25029199
http://dx.doi.org/10.1371/journal.pone.0102777

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4100920/
https://www.ncbi.nlm.nih.gov/pubmed/25029199
http://dx.doi.org/10.1371/journal.pone.0102777

Ejemplares similares